SCHEMBL28565368

SCHEMBL28565368

Cc1cc(Nc2cc(-c3ccccc3)nc(S(=O)(=O)c3ccc(NC(=O)CN(C)C)cc3)n2)[nH]n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKB Q96GD4 5/20 0.44
MAPT P10636 7/20 0.40
AURKA O14965 3/20 0.40
KDM4E B2RXH2 4/20 0.38
ALDH1A1 P00352 3/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
HPGD P15428 1/20 0.38
CNR1 P21554 2/20 0.38
HTT P42858 2/20 0.38
LMNA P02545 1/20 0.38
GPR55 Q9Y2T6 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
TP53 P04637 1/20 0.37
AURKC Q9UQB9 1/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36
NPC1 O15118 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28021591 0.91 AURKB (0.51) AURKBMAPTAURKAKDM4EALDH1A1
SCHEMBL28022116 0.88 ADORA1 (0.47) AURKBMAPTAURKAKDM4EALDH1A1
SCHEMBL28557357 0.88 AURKB (0.49) AURKBMAPTAURKAKDM4EALDH1A1
SCHEMBL28548957 0.85 ADORA1 (0.44) AURKBMAPTAURKAKDM4EALDH1A1
SCHEMBL28553059 0.84 ADORA1 (0.45) AURKBMAPTAURKAMEN1KMT2A
SCHEMBL28549341 0.83 ALDH1A1 (0.45) AURKBMAPTKDM4EALDH1A1MEN1
SCHEMBL2203979 0.82 AURKB (0.65) AURKBMAPTAURKAAURKC
SCHEMBL28022051 0.82 HRH4 (0.41) AURKBMAPTAURKALMNASMN1; SMN2
SCHEMBL28022063 0.81 SMN1; SMN2 (0.42) AURKBMAPTAURKAKDM4EALDH1A1
SCHEMBL28021745 0.81 AURKB (0.41) AURKBMAPTAURKAKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112755193-A Method of treating malignancies with anti-tyrosine kinase inhibitors using dianhydrogalactitol or a derivative thereof 德玛医药 2021-05-07 CN disclosed